Equity Overview
Price & Market Data
Price: $8.11
Daily Change: -$0.43 / 5.30%
Daily Range: $8.01 - $8.80
Market Cap: $436,631,808
Daily Volume: 3,597,516
Performance Metrics
1 Week: -36.88%
1 Month: -74.42%
3 Months: -68.39%
6 Months: -50.61%
1 Year: -1.82%
YTD: -70.24%
Company Details
Employees: 52
Sector: Health technology
Industry: Biotechnology
Country:
Details
Upstream Bio, Inc., a clinical-stage biotechnology company, develops treatments for inflammatory diseases focusing on severe respiratory disorders. It offers verekitug, which is in Phase 2 clinical development for the treatment of severe asthma and chronic rhinosinusitis with nasal polyps, and in Phase I clinical trial for treating chronic obstructive pulmonary disease. The company was incorporated in 2021 and is headquartered in Waltham, Massachusetts.